authors
- Arranz JA
- Barragan P
- for the BICOMBO study group
- Fuster M
- GUTIERREZ RODERO, FELIX
- Knobel H
- Llibre JM
- Lonca M
- Miro J.M
- Podzamczer D
- Ribera E
- Sanz J
Efficacy and Safety of NRTI¿s Switch to Tenofovir Plus Emtricitabine (Truvada®) vs. Abacavir Plus Lamivudine (Kivexa®) in Patients with Virologic Suppression Receiving a Lamivudine Containing HAART and Never Exposed Tenofovir (TDF) or Abacavir (ABC): A Subanalysis of the BICOMBO Study.
Conference Paper
2007
Congress communication
- Overview